Supplementation with NAD+ and its precursors: A rescue of female reproductive diseases
- PMID: 38698835
- PMCID: PMC11063225
- DOI: 10.1016/j.bbrep.2024.101715
Supplementation with NAD+ and its precursors: A rescue of female reproductive diseases
Abstract
Nicotinamide adenine dinucleotide (NAD+) is an essential coenzyme involved in many pathophysiological processes. Supplementation with NAD+ and its precursors has been demonstrated as an emerging therapeutic strategy for the diseases. NAD+ also plays an important role in the reproductive system. Here, we summarize the function of NAD+ in various reproductive diseases and review the application of NAD+ and its precursors in the preservation of reproductive capacity and the prevention of embryonic malformations. It is shown that NAD+ shows good promise as a therapeutic approach for saving reproductive capacity.
Keywords: Female reproduction; Gynecologic tumor; NAD+; NAD+ precursors; Nicotinamide adenine dinucleotide; Ovarian diseases.
© 2024 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures




Similar articles
-
Role of Nicotinamide Adenine Dinucleotide and Related Precursors as Therapeutic Targets for Age-Related Degenerative Diseases: Rationale, Biochemistry, Pharmacokinetics, and Outcomes.Antioxid Redox Signal. 2019 Jan 10;30(2):251-294. doi: 10.1089/ars.2017.7269. Epub 2018 May 11. Antioxid Redox Signal. 2019. PMID: 29634344 Free PMC article. Review.
-
Pharmacology and Potential Implications of Nicotinamide Adenine Dinucleotide Precursors.Aging Dis. 2021 Dec 1;12(8):1879-1897. doi: 10.14336/AD.2021.0523. eCollection 2021 Dec. Aging Dis. 2021. PMID: 34881075 Free PMC article. Review.
-
Nicotinamide Adenine Dinucleotide in the Development and Treatment of Cardiac Remodeling and Aging.Mini Rev Med Chem. 2022;22(18):2310-2317. doi: 10.2174/1389557522666220304121917. Mini Rev Med Chem. 2022. PMID: 35249481
-
A metabolic signature for NADSYN1-dependent congenital NAD deficiency disorder.J Clin Invest. 2024 Feb 15;134(4):e174824. doi: 10.1172/JCI174824. J Clin Invest. 2024. PMID: 38357931 Free PMC article.
-
NAD+ Precursors in Human Health and Disease: Current Status and Future Prospects.Antioxid Redox Signal. 2023 Dec;39(16-18):1133-1149. doi: 10.1089/ars.2023.0354. Epub 2023 Aug 4. Antioxid Redox Signal. 2023. PMID: 37335049 Review.
Cited by
-
A zebrafish model of nicotinamide adenine dinucleotide (NAD+) deficiency-derived congenital disorders.bioRxiv [Preprint]. 2025 Jan 10:2025.01.10.632366. doi: 10.1101/2025.01.10.632366. bioRxiv. 2025. PMID: 39829932 Free PMC article. Preprint.
-
Connecting the Dots: Mitochondrial Dysfunction, PCOS, and Insulin Resistance-Insights and Therapeutic Advances.Int J Mol Sci. 2025 Jun 28;26(13):6233. doi: 10.3390/ijms26136233. Int J Mol Sci. 2025. PMID: 40650016 Free PMC article. Review.
-
Reverse Effects of Nicotinamide Mononucleotide Supplementation on Declining Quality of Oocytes With Polycystic Ovary Syndrome.FASEB J. 2025 Jul 31;39(14):e70846. doi: 10.1096/fj.202500921R. FASEB J. 2025. PMID: 40678956 Free PMC article.
-
Role of PARP Inhibitors: A New Hope for Breast Cancer Therapy.Int J Mol Sci. 2025 Mar 19;26(6):2773. doi: 10.3390/ijms26062773. Int J Mol Sci. 2025. PMID: 40141415 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources